Published in Gene Therapy Weekly, November 17th, 1997
One of the major limitations of chemotherapy is its toxic effects on hematologic tissues. Several studies have transduced hematopoietic cells successfully with the mdr-1 gene to protect the cells from the toxic effects of chemotherapy. Not only can this protect these cells from standard doses of chemotherapeutics, but it could also allow for dosage escalation in situations where the cancer cells have lost their sensitivity to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.